Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $14,615 | 9 | 39.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,730 | 11 | 34.5% |
| Consulting Fee | $4,475 | 3 | 12.1% |
| Food and Beverage | $2,588 | 16 | 7.0% |
| Honoraria | $2,510 | 2 | 6.8% |
| Education | $10.00 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Veloxis Pharmaceuticals, Inc. | $32,345 | 32 | $0 (2022) |
| Astellas Pharma US Inc | $3,250 | 2 | $0 (2017) |
| ZOLL Medical Corporation | $475.00 | 1 | $0 (2024) |
| CSL Behring | $287.48 | 3 | $0 (2018) |
| PFIZER INC. | $220.00 | 1 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $120.52 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $106.58 | 1 | $0 (2017) |
| Intuitive Surgical, Inc. | $77.90 | 1 | $0 (2019) |
| Medical Device Business Services, Inc. | $46.73 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $475.00 | 1 | ZOLL Medical Corporation ($475.00) |
| 2022 | $2,510 | 2 | Veloxis Pharmaceuticals, Inc. ($2,510) |
| 2020 | $6,810 | 5 | Veloxis Pharmaceuticals, Inc. ($6,810) |
| 2019 | $14,597 | 16 | Veloxis Pharmaceuticals, Inc. ($14,398) |
| 2018 | $5,519 | 6 | Veloxis Pharmaceuticals, Inc. ($5,248) |
| 2017 | $7,018 | 13 | Veloxis Pharmaceuticals, Inc. ($3,378) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/30/2024 | ZOLL Medical Corporation | Defibrillator (Device) | Consulting Fee | Cash or cash equivalent | $475.00 | General |
| Category: Resuscitation | ||||||
| 06/02/2022 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Honoraria | Cash or cash equivalent | $2,010.00 | General |
| Category: Immunosuppresant | ||||||
| 03/15/2022 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Honoraria | Cash or cash equivalent | $500.00 | General |
| Category: Immunosuppresant | ||||||
| 07/09/2020 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,150.00 | General |
| Category: Immunosuppressant | ||||||
| 05/07/2020 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Immunosuppressant | ||||||
| 02/12/2020 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Immunosuppressant | ||||||
| 02/12/2020 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Travel and Lodging | Cash or cash equivalent | $1,554.70 | General |
| Category: Immunosuppressant | ||||||
| 02/12/2020 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Travel and Lodging | Cash or cash equivalent | $105.27 | General |
| Category: Immunosuppressant | ||||||
| 07/31/2019 | E.R. Squibb & Sons, L.L.C. | NULOJIX (Biological) | Food and Beverage | Cash or cash equivalent | $120.52 | General |
| Category: Immunology | ||||||
| 06/02/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Travel and Lodging | In-kind items and services | $2,500.00 | General |
| Category: Immunosuppressant | ||||||
| 04/12/2019 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $77.90 | General |
| Category: SURGERY | ||||||
| 04/09/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Travel and Lodging | In-kind items and services | $2,500.00 | General |
| Category: Immunosuppressant | ||||||
| 04/09/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $41.68 | General |
| Category: Immunosuppressant | ||||||
| 04/09/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $26.10 | General |
| Category: Immunosuppressant | ||||||
| 03/12/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Travel and Lodging | In-kind items and services | $2,500.00 | General |
| Category: Immunosuppressant | ||||||
| 03/12/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Travel and Lodging | In-kind items and services | $1,644.29 | General |
| Category: Immunosuppressant | ||||||
| 03/12/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $134.25 | General |
| Category: Immunosuppressant | ||||||
| 03/12/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $104.19 | General |
| Category: Immunosuppressant | ||||||
| 02/27/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Food and Beverage | In-kind items and services | $479.59 | General |
| Category: Immunosuppressant | ||||||
| 02/06/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Travel and Lodging | In-kind items and services | $2,500.00 | General |
| Category: Immunosuppressant | ||||||
| 02/06/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Food and Beverage | In-kind items and services | $173.81 | General |
| Category: Immunosuppressant | ||||||
| 02/06/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $124.01 | General |
| Category: Immunosuppressant | ||||||
| 01/31/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Travel and Lodging | In-kind items and services | $1,250.00 | General |
| Category: Immunosuppressant | ||||||
| 01/31/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Food and Beverage | In-kind items and services | $420.31 | General |
| Category: Immunosuppressant | ||||||
| 06/09/2018 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $220.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 16 | 27 | $5,859 | $1,827 |
| 2022 | 1 | 17 | 25 | $5,425 | $1,474 |
| 2021 | 6 | 119 | 175 | $235,350 | $45,324 |
| 2020 | 3 | 126 | 253 | $280,860 | $57,336 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 27 | $5,859 | $1,827 | 31.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 17 | 25 | $5,425 | $1,474 | 27.2% |
| 50360 | Transplantation of donor kidney | Facility | 2021 | 15 | 15 | $178,260 | $33,766 | 18.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 50 | 106 | $23,002 | $6,413 | 27.9% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2021 | 13 | 13 | $14,300 | $1,506 | 10.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 12 | 12 | $4,020 | $1,397 | 34.8% |
| 50327 | Preparation of donor kidney for transplantation, venous connection | Facility | 2021 | 11 | 11 | $11,880 | $1,130 | 9.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 18 | 18 | $3,888 | $1,112 | 28.6% |
| 50360 | Transplantation of donor kidney | Facility | 2020 | 21 | 21 | $230,550 | $43,647 | 18.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 71 | 198 | $42,966 | $11,656 | 27.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 34 | 34 | $7,344 | $2,033 | 27.7% |
About Dr. Joseph Leventhal, MD
Dr. Joseph Leventhal, MD is a Transplant Surgery healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124050406.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Leventhal, MD has received a total of $36,929 in payments from pharmaceutical and medical device companies, with $475.00 received in 2024. These payments were reported across 43 transactions from 9 companies. The most common payment nature is "Travel and Lodging" ($14,615).
As a Medicare-enrolled provider, Leventhal has provided services to 278 Medicare beneficiaries, totaling 480 services with total Medicare billing of $105,961. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Transplant Surgery
- Location Chicago, IL
- Active Since 07/07/2006
- Last Updated 02/12/2020
- Taxonomy Code 204F00000X
- Entity Type Individual
- NPI Number 1124050406
Products in Payments
- Envarsus (Drug) $23,718
- Envarsus XR (SP) (Drug) $5,248
- Envarsus XR (Drug) $3,378
- Defibrillator (Device) $475.00
- Product in Development (Biological) $236.74
- NULOJIX (Biological) $120.52
- Da Vinci Surgical System (Device) $77.90
- EVARREST (Biological) $46.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Transplant Surgery Doctors in Chicago
Piotr Witkowski
Transplant Surgery — Payments: $163,367
John Fung
Transplant Surgery — Payments: $124,227
Vinayak Rohan, M.d, M.D
Transplant Surgery — Payments: $61,537
Dr. Lloyd Brown, M.d, M.D
Transplant Surgery — Payments: $16,908
Daniel Borja Cacho, Md, MD
Transplant Surgery — Payments: $15,171
Dr. Oyedolamu Olaitan, Mbbs, Facs, Febs, MBBS, FACS, FEBS
Transplant Surgery — Payments: $12,508